Trends in excess mortality in follicular lymphoma at a population level.

@article{Mounier2015TrendsIE,
  title={Trends in excess mortality in follicular lymphoma at a population level.},
  author={Morgane Mounier and Nadine Bossard and Aur{\'e}lien Belot and Laurent Remontet and Jean Iwaz and Myl{\`e}ne Dandoit and St{\'e}phanie Girard-Boulanger and Aur{\'e}lie Herry and Anne-Sophie Woronoff and R O Casasnovas and Marck Maynadi{\'e} and Roch Giorgi},
  journal={European journal of haematology},
  year={2015},
  volume={94 2},
  pages={120-9}
}
BACKGROUND Since the 1990s and since the development of humanised monoclonal antibodies in 1998, the treatment of non-Hodgkin lymphoma has undergone profound changes. Follicular lymphoma (FL) was the first to benefit from this treatment, and several clinical trials have shown a significant improvement in overall survival, but little information is available at a population level. OBJECTIVE Our objective was to estimate changes in FL-specific mortality at a population level, with an… CONTINUE READING